Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

Similar articles for PubMed (Select 22882924)

1.

Combined effect of atorvastatin and probucol on plasma cystatin C levels and severity of coronary lesion in patients with borderline coronary lesion.

Ge CJ, Lü SZ, Feng LX, Huo Y, Song XT, Chen X, Meng K, Yuan F.

Chin Med J (Engl). 2012 Jul;125(14):2472-6.

PMID:
22882924
2.

Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.

Bonnet J, McPherson R, Tedgui A, Simoneau D, Nozza A, Martineau P, Davignon J; CAP Investigators.

Clin Ther. 2008 Dec;30(12):2298-313. doi: 10.1016/j.clinthera.2008.12.023.

PMID:
19167589
3.

Clinical prognostic significance of plasma cystatin C levels among patients with acute coronary syndrome.

Ge C, Ren F, Lu S, Ji F, Chen X, Wu X.

Clin Cardiol. 2009 Nov;32(11):644-8. doi: 10.1002/clc.20672.

PMID:
19938052
4.

[Effects of atorvastatin, alone and in combination with probucol on endothelial function in patients with acute coronary syndrome].

Zheng XY, Liu L, Zhao SP.

Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Oct;37(10):900-3. Chinese.

PMID:
20137540
5.

[Efficacy and safety of extended-release niacin alone or with atorvastatin for lipid profile modification].

Li XP, Duan J, Zhao SP, Tan MY, Xu ZM, Zhang DQ.

Zhonghua Yi Xue Za Zhi. 2006 Sep 12;86(34):2399-403. Chinese.

PMID:
17156651
6.
7.

[Changes of blood lipids in colorectal cancer patients with coronary heart disease and value of lipid-lowering therapy with statins].

Liang ZT, Wang XP, Zeng QT, Liao YH, Gao CY, Li MW.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 May;28(5):863-5. Chinese.

8.

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.

Athyros VG, Papageorgiou AA, Mercouris BR, Athyrou VV, Symeonidis AN, Basayannis EO, Demitriadis DS, Kontopoulos AG.

Curr Med Res Opin. 2002;18(4):220-8.

PMID:
12201623
9.
10.

Effects of low doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol levels in patients with hypercholesterolemia.

Branchi A, Fiorenza AM, Torri A, Muzio F, Berra C, Colombo E, Dalla Valle E, Rovellini A, Sommariva D.

Clin Ther. 2001 Jun;23(6):851-7.

PMID:
11440285
11.

Probucol and atorvastatin decrease urinary 8-hydroxy-2'-deoxyguanosine in patients with diabetes and hypercholesterolemia.

Endo K, Miyashita Y, Sasaki H, Ebisuno M, Ohira M, Saiki A, Koide N, Oyama T, Takeyoshi M, Shirai K.

J Atheroscler Thromb. 2006 Feb;13(1):68-75.

12.

The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels.

Keleş T, Akar Bayram N, Kayhan T, Canbay A, Sahin D, Durmaz T, Ozdemir O, Aydoğdu S, Diker E.

Anadolu Kardiyol Derg. 2008 Dec;8(6):407-12.

13.

The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol.

Kanadaşi M, Cayli M, Demirtaş M, Inal T, Demir M, Koç M, Avkaroğullari M, Dönmez Y, Usal A, Alhan CC, San M.

Heart Vessels. 2006 Sep;21(5):291-7. Epub 2006 Sep 29.

PMID:
17151816
14.

A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study.

Olsson AG, Eriksson M, Johnson O, Kjellström T, Lanke J, Larsen ML, Pedersen T, Tikkanen MJ, Wiklund O; 3T Study Investigators.

Clin Ther. 2003 Jan;25(1):119-38.

PMID:
12637115
15.
16.

[Evaluating the efficacy and tolerance of atorvastatin in hyperlipidemia in general practice (SWITCH Study)].

Noseda G, Darioli R, Keller U, Mordasini R, Shokry A, Schaffhauser B, Riesen W.

Schweiz Med Wochenschr. 2000 Jun 10;130(23):889-95. German.

PMID:
10897490
17.

Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.

Castaño G, Mas R, Fernández L, Illnait J, Mesa M, Alvarez E, Lezcay M.

Drugs Aging. 2003;20(2):153-63.

PMID:
12534315
18.

[Effects of probucol, aspirin and atorvastatin combination therapy upon atherosclerosis].

Meng XP, Wang SX, Zhang JC, Li ZX, Geng L, Yin CY.

Zhonghua Yi Xue Za Zhi. 2009 Jul 28;89(28):1986-8. Chinese.

PMID:
19950575
19.
20.

Comparison of efficacy and safety of atorvastatin and simvastatin in patients with dyslipidemia with and without coronary heart disease.

Karalis DG, Ross AM, Vacari RM, Zarren H, Scott R.

Am J Cardiol. 2002 Mar 15;89(6):667-71.

PMID:
11897207
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk